Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

T lymphoblastic leukaemia and the central nervous system

Abstract

Of 100 children and adolescents with lymphoblastic leukaemia (ALL) seen over a 6-year period, 25 developed clinically evident infiltration of the central nervous system (CNS), despite early treatment with cranial radiotherapy and intrathecal methotrexate. Nine of these 25 had the features of T ALL, though there were only 17 such patients overall. Not only did those with T ALL get CNS disease more frequently, but they did so much sooner after diagnosis (P less than 0.001) and more commonly had associated facial palsies (P less than 0.05). The tendency to develop CNS infiltration appeared to be significantly related to the possession of T-cell markers (P less than 0.02), but not to the diagnostic white cell count (P = 0.37). These findings suggest that current CNS prophylactic therapy is ineffective in most patients with T ALL.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lilleyman, J., Sugden, P. T lymphoblastic leukaemia and the central nervous system. Br J Cancer 43, 320–323 (1981). https://doi.org/10.1038/bjc.1981.50

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1981.50

Search

Quick links